Literature DB >> 8692969

Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

B S Nepom1, G T Nepom, M Coleman, W W Kwok.   

Abstract

Position 57 in the beta chain of HLA class II molecules maintains an Asp/non-Asp dimorphism that has been conserved through evolution and is implicated in susceptibility to some autoimmune diseases. The latter effect may be due to the influence of this residue on the ability of class II alleles to bind specific pathogenic peptides. We utilized highly homologous pairs of both DR and DQ alleles that varied at residue 57 to investigate the impact of this dimorphism on binding of model peptides. Using a direct binding assay of biotinylated peptides on whole cells expressing the desired alleles, we report several peptides that bind differentially to the allele pairs depending on the presence or absence of Asp at position 57. Peptides with negatively charged residues at anchor position 9 bind well to alleles not containing Asp at position 57 in the beta chain but cannot bind well to homologous Asp-positive alleles. By changing the peptides at the single residue predicted to interact with this position 57, we demonstrate a drastically altered or reversed pattern of binding. Ala analog peptides confirm these interactions and identify a limited set of interaction sites between the bound peptides and the class II molecules. Clarification of the impact of specific class II polymorphisms on generating unique allele-specific peptide binding "repertoires" will aid in our understanding of the development of specific immune responses and HLA-associated diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692969      PMCID: PMC38960          DOI: 10.1073/pnas.93.14.7202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Definition of a DQ3.1-specific binding motif.

Authors:  J Sidney; C Oseroff; M F del Guercio; S Southwood; J I Krieger; G Y Ishioka; K Sakaguchi; E Appella; A Sette
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

2.  Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients.

Authors:  C R Hume; L A Shookster; N Collins; R O'Reilly; J S Lee
Journal:  Hum Immunol       Date:  1989-05       Impact factor: 2.850

3.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

4.  Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.

Authors:  K W Marshall; A F Liu; J Canales; B Perahia; B Jorgensen; R D Gantzos; B Aguilar; B Devaux; J B Rothbard
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

Review 5.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  HLA-DQ polymorphisms are highly selective for peptide binding interactions.

Authors:  W W Kwok; G T Nepom; F C Raymond
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

8.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.

Authors:  R M Chicz; W S Lane; R A Robinson; M Trucco; J L Strominger; J C Gorga
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

9.  Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.

Authors:  X T Fu; C P Bono; S L Woulfe; C Swearingen; N L Summers; F Sinigaglia; A Sette; B D Schwartz; R W Karr
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases.

Authors:  K W Wucherpfennig; J L Strominger
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

2.  Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.

Authors:  Anish Suri; James J Walters; Michael L Gross; Emil R Unanue
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

3.  Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.

Authors:  Anthony W Purcell; Sri H Ramarathinam; Nicola Ternette
Journal:  Nat Protoc       Date:  2019-05-15       Impact factor: 13.491

4.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

5.  Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.

Authors:  I-Ting Chow; Eddie A James; Theresa J Gates; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

6.  DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.

Authors:  I-Ting Chow; Eddie A James; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  Mol Immunol       Date:  2011-12-23       Impact factor: 4.407

7.  Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models.

Authors:  Edward F Rosloniec; Tilmann Brandstetter; Sigmar Leyer; Franz-Werner Schwaiger; Zoltan A Nagy
Journal:  J Autoimmun       Date:  2006-11-01       Impact factor: 7.094

8.  Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles.

Authors:  Ruth A Ettinger; Antonis K Moustakas; Suzanne D Lobaton
Journal:  Immunogenetics       Date:  2004-10-23       Impact factor: 2.846

9.  Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Authors:  Gunnveig Grodeland; Agnete Brunsvik Fredriksen; Geir Åge Løset; Elisabeth Vikse; Lars Fugger; Bjarne Bogen
Journal:  J Immunol       Date:  2016-09-26       Impact factor: 5.422

10.  Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.

Authors:  Yukinori Okada; Kwangwoo Kim; Buhm Han; Nisha E Pillai; Rick T-H Ong; Woei-Yuh Saw; Ma Luo; Lei Jiang; Jian Yin; So-Young Bang; Hye-Soon Lee; Matthew A Brown; Sang-Cheol Bae; Huji Xu; Yik-Ying Teo; Paul I W de Bakker; Soumya Raychaudhuri
Journal:  Hum Mol Genet       Date:  2014-07-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.